Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Bret

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Cell Cycle (Georgetown, Tex.)|May 28, 2013
Nucleotide excision DNA repair pathway as a therapeutic target in patients with high-risk diffuse large B cell lymphomaCaroline Bret, Bernard Klein, Jérôme Moreaux
Oncotarget|March 14, 2013
Gene expression-based risk score in diffuse large B-cell lymphomaCaroline Bret, Bernard Klein, Jérôme Moreaux
Frontiers in Genetics|October 18, 2019
Treatment May Be Harmful: Mechanisms/Prediction/Prevention of Drug-Induced DNA Damage and Repair in Multiple MyelomaClaire Gourzones, Caroline Bret, Jerome Moreaux
Expert Review of Hematology|January 14, 2016
Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapyCaroline Bret, Elena Viziteu, Alboukadel Kassambara, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 10, 2024
BHLHE41, a transcriptional repressor involved in physiological processes and tumor developmentCaroline Bret, Fabienne Desmots-Loyer, Jérôme Moreaux, et al.
Journal of Clinical Medicine|July 25, 2019
Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic ImpactJulie Devin, Alboukadel Kassambara, Angélique Bruyer, et al.
Cancers|October 10, 2020
DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic TargetsLudovic Gabellier, Caroline Bret, Guillaume Bossis, et al.
Cytometry. Part B, Clinical Cytometry|September 19, 2024
CD38, CD39, and BCL2 differentiate disseminated forms of high-grade B-cell lymphomas in biological fluids from Burkitt lymphoma and diffuse large B-cell lymphomaPauline Marianini, Vanessa Lacheretz-Szablewski, Marion Almeras, et al.
Journal of Translational Medicine|May 24, 2011
SULFs in human neoplasia: implication as progression and prognosis factorsCaroline Bret, Jérôme Moreaux, Jean-François Schved, et al.
Journal of Cutaneous Pathology|April 17, 2018
Cutaneous presentation preceding acute myeloid leukemia with CD4+/CD56+ expression misdiagnosed as a blastic plasmocytoid dendritic cell neoplasm: A case reportVanessa Szablewski, Valérie Costes, Caroline Bret, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Cell Cycle (Georgetown, Tex.)|May 28, 2013
Nucleotide excision DNA repair pathway as a therapeutic target in patients with high-risk diffuse large B cell lymphomaCaroline Bret, Bernard Klein, Jérôme Moreaux
Oncotarget|March 14, 2013
Gene expression-based risk score in diffuse large B-cell lymphomaCaroline Bret, Bernard Klein, Jérôme Moreaux
Frontiers in Genetics|October 18, 2019
Treatment May Be Harmful: Mechanisms/Prediction/Prevention of Drug-Induced DNA Damage and Repair in Multiple MyelomaClaire Gourzones, Caroline Bret, Jerome Moreaux
Expert Review of Hematology|January 14, 2016
Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapyCaroline Bret, Elena Viziteu, Alboukadel Kassambara, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 10, 2024
BHLHE41, a transcriptional repressor involved in physiological processes and tumor developmentCaroline Bret, Fabienne Desmots-Loyer, Jérôme Moreaux, et al.
Journal of Clinical Medicine|July 25, 2019
Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic ImpactJulie Devin, Alboukadel Kassambara, Angélique Bruyer, et al.
Cancers|October 10, 2020
DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic TargetsLudovic Gabellier, Caroline Bret, Guillaume Bossis, et al.
Cytometry. Part B, Clinical Cytometry|September 19, 2024
CD38, CD39, and BCL2 differentiate disseminated forms of high-grade B-cell lymphomas in biological fluids from Burkitt lymphoma and diffuse large B-cell lymphomaPauline Marianini, Vanessa Lacheretz-Szablewski, Marion Almeras, et al.
Journal of Translational Medicine|May 24, 2011
SULFs in human neoplasia: implication as progression and prognosis factorsCaroline Bret, Jérôme Moreaux, Jean-François Schved, et al.
Journal of Cutaneous Pathology|April 17, 2018
Cutaneous presentation preceding acute myeloid leukemia with CD4+/CD56+ expression misdiagnosed as a blastic plasmocytoid dendritic cell neoplasm: A case reportVanessa Szablewski, Valérie Costes, Caroline Bret, et al.
Pageof 5